293 related articles for article (PubMed ID: 37895350)
1. Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review.
Bruno G; Buccoliero GB
Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895350
[TBL] [Abstract][Full Text] [Related]
2. Emerging pharmacological strategies for treating and preventing mpox.
Grosenbach DW; Russo AT; Blum ED; Hruby DE
Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
[TBL] [Abstract][Full Text] [Related]
3. Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T
Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
[TBL] [Abstract][Full Text] [Related]
4. Mpox in people with advanced HIV infection: a global case series.
Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
[TBL] [Abstract][Full Text] [Related]
5. Antivirals With Activity Against Mpox: A Clinically Oriented Review.
Siegrist EA; Sassine J
Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001
[TBL] [Abstract][Full Text] [Related]
6. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus.
Chenchula S; Ghanta MK; Amerneni KC; Rajakarunakaran P; Chandra MB; Chavan M; Gupta R
Arch Virol; 2023 Jun; 168(7):195. PubMed ID: 37386209
[TBL] [Abstract][Full Text] [Related]
7. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
[TBL] [Abstract][Full Text] [Related]
9. Antivirals for the treatment of Monkeypox: utilization in the general and HIV-positive population and gaps for research. A short narrative review.
Ivanov DT; Slabakova YA; Argirova RM; Valkov TK
Infez Med; 2023; 31(2):186-194. PubMed ID: 37283638
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
[TBL] [Abstract][Full Text] [Related]
11. Mpox and HIV: a Narrative Review.
Saldana CS; Kelley CF; Aldred BM; Cantos VD
Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
De Clercq E; Jiang Y; Li G
Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
[TBL] [Abstract][Full Text] [Related]
13. Tecovirimat for the treatment of severe Mpox in Germany.
Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic targets for Mpox: the evidence to date.
Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
[TBL] [Abstract][Full Text] [Related]
15. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
[TBL] [Abstract][Full Text] [Related]
16. Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists.
Gupta AK; Talukder M; Rosen T; Piguet V
Am J Clin Dermatol; 2023 Jul; 24(4):541-556. PubMed ID: 37106278
[TBL] [Abstract][Full Text] [Related]
17. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
Almehmadi M; Allahyani M; Alsaiari AA; Alshammari MK; Alharbi AS; Hussain KH; Alsubaihi LI; Kamal M; Alotaibi SS; Alotaibi AN; Aldhafeeri AA; Imran M
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146675
[TBL] [Abstract][Full Text] [Related]
18. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
[TBL] [Abstract][Full Text] [Related]
19. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
[TBL] [Abstract][Full Text] [Related]
20. A Prolonged Case of Severe Mpox as an Opportunistic Infection in Advanced AIDS.
Malka MS; Parkinson M; Zucker J; McLean JR; Pereira MR; Yin MT; Gunaratne SH
Cureus; 2024 May; 16(5):e59947. PubMed ID: 38854169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
